prednisolone has been researched along with Hemangioendothelioma in 26 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Hemangioendothelioma: A neoplasm derived from blood vessels, characterized by numerous prominent endothelial cells that occur singly, in aggregates, and as the lining of congeries of vascular tubes or channels. Hemangioendotheliomas are relatively rare and are of intermediate malignancy (between benign hemangiomas and conventional angiosarcomas). They affect men and women about equally and rarely develop in childhood. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1866)
| Excerpt | Relevance | Reference |
|---|---|---|
| "There is currently no consensus on the second-line management of Kaposiform hemangioendothelioma (KHE) that was resistant to prednisolone and vincristine." | 7.81 | Successful treatment of Kaposiform hemangioendothelioma with everolimus. ( Ito, S; Miyazaki, O; Mori, T; Nakazawa, A; Terashima, K; Uno, T, 2015) |
| "Sirolimus was added; he became transfusion independent with no further bleeding and reduction in tumor size." | 5.48 | Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus. ( Cashell, J; Helm, K; Smink, GM; Xavier, F, 2018) |
| "Sirolimus was effective and safe for the treatment of progressive KHE." | 5.46 | Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study. ( Chen, S; Ji, Y; Li, K; Li, Y; Liu, X; Lu, G; Tang, X; Wang, C; Wang, Q; Wu, H; Xia, C; Xiang, B; Xu, T; Xu, Z; Yang, G; Yang, K; Yao, W, 2017) |
| "Sirolimus is an effective therapy for children with kaposiform hemangioendothelioma with or without the Kasabach-Merritt phenomenon." | 3.88 | ( Dillingham, CS; Givner, LB; McLean, TW; Rinker, EK; Russell, TB, 2018) |
| "There is currently no consensus on the second-line management of Kaposiform hemangioendothelioma (KHE) that was resistant to prednisolone and vincristine." | 3.81 | Successful treatment of Kaposiform hemangioendothelioma with everolimus. ( Ito, S; Miyazaki, O; Mori, T; Nakazawa, A; Terashima, K; Uno, T, 2015) |
| " A 28-day-old boy with TSH level of 77 mIU/mL on neonatal screening and diagnosed as congenital hypothyroidism was started on L-thyroxine (L-T4) (11 μg/kg/day) therapy on the 21(th) day of life." | 3.76 | Hypothyroidism due to hepatic hemangioendothelioma: a case report. ( Ağladioğlu, SY; Aycan, Z; Baş, VN; Bozkurt, C; Çetinkaya, S; Kendirci, HN; Özdemir, S, 2010) |
| "Sirolimus was added; he became transfusion independent with no further bleeding and reduction in tumor size." | 1.48 | Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus. ( Cashell, J; Helm, K; Smink, GM; Xavier, F, 2018) |
| "Sirolimus was effective and safe for the treatment of progressive KHE." | 1.46 | Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study. ( Chen, S; Ji, Y; Li, K; Li, Y; Liu, X; Lu, G; Tang, X; Wang, C; Wang, Q; Wu, H; Xia, C; Xiang, B; Xu, T; Xu, Z; Yang, G; Yang, K; Yao, W, 2017) |
| "Infantile hemangioendothelioma is a rare benign vascular tumor of the liver." | 1.35 | Infantile hepatic hemangioendothelioma: an 8-month old infant successfully treated with a corticosteroid. ( Al-Tonbary, Y; Fouda, A, 2009) |
| "Hepatic hemangioendotheliomas are rare tumors in childhood." | 1.34 | Infantile hepatic hemangioendothelioma: clinical presentation and treatment. ( Ozkan, TB; Sevinir, B, 2007) |
| "Hepatic hemangioendothelioma is rare." | 1.31 | Infantile hepatic hemangioendothelioma presenting as early heart failure: report of two cases. ( Ko, SF; Kuo, HW; Liang, CD; Lu, CC; Tiao, MM, 2002) |
| "Prednisolone was ineffective when application was initiated after arthritis was fully developed, i." | 1.29 | Prednisolone reduces experimental arthritis, and inflammatory tissue destruction in SCID mice infected with Borrelia burgdorferi. ( Böggemeyer, E; Del Pozo, E; Hurtenbach, U; Museteanu, C; Simon, MM; Stehle, T, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.85) | 18.7374 |
| 1990's | 5 (19.23) | 18.2507 |
| 2000's | 7 (26.92) | 29.6817 |
| 2010's | 11 (42.31) | 24.3611 |
| 2020's | 2 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Ji, Y | 2 |
| Chen, S | 2 |
| Zhou, J | 1 |
| Yang, K | 2 |
| Zhang, X | 1 |
| Xiang, B | 2 |
| Qiu, T | 1 |
| Gong, X | 1 |
| Zhang, Z | 1 |
| Lan, Y | 1 |
| Hu, F | 1 |
| Kong, F | 1 |
| Qiu, Q | 1 |
| Zhang, Y | 1 |
| Li, K | 1 |
| Xu, Z | 1 |
| Yao, W | 1 |
| Lu, G | 1 |
| Liu, X | 1 |
| Xia, C | 1 |
| Wang, Q | 1 |
| Li, Y | 1 |
| Wang, C | 1 |
| Yang, G | 1 |
| Tang, X | 1 |
| Xu, T | 1 |
| Wu, H | 1 |
| Russell, TB | 1 |
| Rinker, EK | 1 |
| Dillingham, CS | 1 |
| Givner, LB | 1 |
| McLean, TW | 1 |
| Cashell, J | 1 |
| Smink, GM | 1 |
| Helm, K | 1 |
| Xavier, F | 1 |
| Emad, A | 1 |
| Fadel, S | 1 |
| El Wakeel, M | 1 |
| Nagy, N | 1 |
| Zamzam, M | 1 |
| Kieran, MW | 1 |
| El Haddad, A | 1 |
| Fichel, F | 1 |
| Eschard, C | 1 |
| Zachar, D | 1 |
| Munzer, M | 1 |
| Bernard, P | 1 |
| Grange, F | 1 |
| Downing, A | 1 |
| Chauhan, A | 1 |
| Lotterman, C | 1 |
| Craver, R | 1 |
| Warrier, R | 1 |
| Uno, T | 1 |
| Ito, S | 1 |
| Nakazawa, A | 2 |
| Miyazaki, O | 1 |
| Mori, T | 1 |
| Terashima, K | 1 |
| Saito, M | 1 |
| Gunji, Y | 1 |
| Kashii, Y | 1 |
| Odaka, J | 1 |
| Yamauchi, T | 1 |
| Kanai, N | 1 |
| Momoi, MY | 1 |
| Al-Tonbary, Y | 1 |
| Fouda, A | 1 |
| Tamai, N | 1 |
| Hashii, Y | 1 |
| Osuga, K | 1 |
| Chihara, T | 1 |
| Morii, E | 1 |
| Aozasa, K | 1 |
| Yoshikawa, H | 1 |
| Çetinkaya, S | 2 |
| Kendirci, HN | 1 |
| Ağladioğlu, SY | 1 |
| Baş, VN | 1 |
| Özdemir, S | 1 |
| Bozkurt, C | 2 |
| Aycan, Z | 1 |
| Incesoy Özdemir, S | 1 |
| Orün, UA | 1 |
| Sahin, G | 1 |
| Yüksek, N | 1 |
| Ertem, U | 1 |
| Kuroda, T | 1 |
| Kumagai, M | 1 |
| Nosaka, S | 1 |
| Takimoto, T | 1 |
| Hoshino, K | 1 |
| Jahnel, J | 1 |
| Lackner, H | 1 |
| Reiterer, F | 1 |
| Urlesberger, B | 1 |
| Urban, C | 1 |
| Lu, CC | 1 |
| Ko, SF | 1 |
| Liang, CD | 1 |
| Kuo, HW | 1 |
| Tiao, MM | 1 |
| Miller, MA | 1 |
| Sandler, AD | 1 |
| Cho, SH | 1 |
| Na, KS | 1 |
| Jothilakshmi, K | 1 |
| Matthai, J | 1 |
| Paul, S | 1 |
| Singal, AK | 1 |
| Sevinir, B | 1 |
| Ozkan, TB | 1 |
| Takato, T | 1 |
| Komuro, Y | 1 |
| Yonehara, Y | 1 |
| Fujikawa, I | 1 |
| Tei, T | 1 |
| Yagasaki, F | 1 |
| Yamamoto, K | 1 |
| Nagata, K | 1 |
| Hamaguchi, H | 1 |
| Miyake, S | 1 |
| Hurtenbach, U | 1 |
| Böggemeyer, E | 1 |
| Stehle, T | 1 |
| Museteanu, C | 1 |
| Del Pozo, E | 1 |
| Simon, MM | 1 |
| Kubo, M | 1 |
| Koga, M | 1 |
| Fujii, T | 1 |
| Kaneko, T | 1 |
| Yamashita, K | 1 |
| Kokubu, T | 1 |
| Bergström, K | 1 |
| Enoksson, P | 1 |
| Gamstorp, I | 1 |
| Naeser, P | 1 |
| Chang, JS | 1 |
| Young, ML | 1 |
| Chuu, WM | 1 |
| Lue, HC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Different Doses of Sirolimus for the Maintenance Treatment of Kaposiform Hemangioendothelioma: a Randomized Controlled Trial[NCT05324384] | Phase 2 | 30 participants (Anticipated) | Interventional | 2022-04-05 | Recruiting | ||
| Sirolimus Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma With Kasabach-Merritt Syndrome[NCT03188068] | Phase 2 | 30 participants (Actual) | Interventional | 2017-06-01 | Completed | ||
| Different Doses of Sirolimus for Kaposiform Hemangioendothelioma: a Randomized Clinical Trial[NCT04775173] | Phase 2 | 79 participants (Actual) | Interventional | 2021-02-17 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for prednisolone and Hemangioendothelioma
| Article | Year |
|---|---|
Infantile cardiac hemangioendothelioma.
Topics: Heart Atria; Heart Neoplasms; Hemangioendothelioma; Humans; Infant; Male; Prednisolone | 1992 |
1 trial available for prednisolone and Hemangioendothelioma
| Article | Year |
|---|---|
Sirolimus plus prednisolone vs sirolimus monotherapy for kaposiform hemangioendothelioma: a randomized clinical trial.
Topics: Hemangioendothelioma; Humans; Infant; Kasabach-Merritt Syndrome; Prednisolone; Sarcoma, Kaposi; Siro | 2022 |
Sirolimus plus prednisolone vs sirolimus monotherapy for kaposiform hemangioendothelioma: a randomized clinical trial.
Topics: Hemangioendothelioma; Humans; Infant; Kasabach-Merritt Syndrome; Prednisolone; Sarcoma, Kaposi; Siro | 2022 |
Sirolimus plus prednisolone vs sirolimus monotherapy for kaposiform hemangioendothelioma: a randomized clinical trial.
Topics: Hemangioendothelioma; Humans; Infant; Kasabach-Merritt Syndrome; Prednisolone; Sarcoma, Kaposi; Siro | 2022 |
Sirolimus plus prednisolone vs sirolimus monotherapy for kaposiform hemangioendothelioma: a randomized clinical trial.
Topics: Hemangioendothelioma; Humans; Infant; Kasabach-Merritt Syndrome; Prednisolone; Sarcoma, Kaposi; Siro | 2022 |
24 other studies available for prednisolone and Hemangioendothelioma
| Article | Year |
|---|---|
Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; C | 2017 |
Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; C | 2017 |
Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; C | 2017 |
Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; C | 2017 |
Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; C | 2017 |
Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; C | 2017 |
Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; C | 2017 |
Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; C | 2017 |
Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; C | 2017 |
Topics: Anti-Bacterial Agents; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Drug Therapy, | 2018 |
Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation Disorders; Child; Hemangioendothel | 2018 |
Outcome of Children Treated for Infantile Hepatic Hemangioendothelioma.
Topics: Antineoplastic Agents, Hormonal; Combined Modality Therapy; Female; Follow-Up Studies; Hemangioendot | 2020 |
[Kaposiform haemangioendothelioma associated with B-cell acute lymphoblastic leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Biopsy; Combined Modality Therapy | 2013 |
Giant vascular malformation with thrombocytopenia in a newborn.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Arm; Female; Hemangioendothelioma; Huma | 2013 |
Successful treatment of Kaposiform hemangioendothelioma with everolimus.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Drug Resistance, Neoplasm; Everolimus; Hemang | 2015 |
Refractory kaposiform hemangioendothelioma that expressed vascular endothelial growth factor receptor (VEGFR)-2 and VEGFR-3: a case report.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Benzamidine | 2009 |
Infantile hepatic hemangioendothelioma: an 8-month old infant successfully treated with a corticosteroid.
Topics: Anti-Inflammatory Agents; Female; Hemangioendothelioma; Humans; Infant; Liver Neoplasms; Prednisolon | 2009 |
Kaposiform hemangioendothelioma arising in the deltoid muscle without the Kasabach-Merritt phenomenon.
Topics: Antineoplastic Agents, Hormonal; Deltoid Muscle; Diagnosis, Differential; Disseminated Intravascular | 2010 |
Hypothyroidism due to hepatic hemangioendothelioma: a case report.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Congenital Hypothyroidism; Hemangioendothelioma; Ho | 2010 |
Successful treatment of pulmonary arteriovenous malformation and infantile hepatic hemangioendothelioma with alpha-interferon.
Topics: Arteriovenous Malformations; Cyanosis; Drug Therapy, Combination; Glucocorticoids; Hemangioendotheli | 2011 |
Critical infantile hepatic hemangioma: results of a nationwide survey by the Japanese Infantile Hepatic Hemangioma Study Group.
Topics: Adrenergic beta-Antagonists; Antineoplastic Agents; Blood Coagulation Disorders; Cardiac Output, Hig | 2011 |
Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: from vincristine to sirolimus.
Topics: Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineopla | 2012 |
Infantile hepatic hemangioendothelioma presenting as early heart failure: report of two cases.
Topics: Female; Heart Failure; Hemangioendothelioma; Hepatic Artery; Humans; Ligation; Liver Neoplasms; Male | 2002 |
Elevated plasma vascular endothelial growth factor levels in 2 patients with hemangioendothelioma.
Topics: Biomarkers, Tumor; Hemangioendothelioma; Hepatectomy; Hip Contracture; Humans; Infant; Liver Neoplas | 2005 |
Haemangioendothelioma on the conjunctiva of the upper eyelid.
Topics: Administration, Oral; Biomarkers, Tumor; Conjunctival Neoplasms; Eyelid Neoplasms; Glucocorticoids; | 2006 |
Symptomatic hepatic hemangioendothelioma in a newborn.
Topics: Disease Progression; Female; Glucocorticoids; Hemangioendothelioma; Humans; Infant, Newborn; Liver N | 2006 |
Infantile hepatic hemangioendothelioma: clinical presentation and treatment.
Topics: Abdomen; Alanine Transaminase; Aspartate Aminotransferases; Dilatation, Pathologic; Female; Glucocor | 2007 |
Giant hemangioma of the parotid gland associated with Kasabach-Merritt syndrome: a case report.
Topics: Hemangioendothelioma; Hemangioma; Humans; Infant; Male; Parotid Neoplasms; Prednisolone; Syndrome; T | 1993 |
[Autopsy case of angiotropic lymphoma complicated with interstitial pneumonia during VEPA therapy and monocytosis in the early stage].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capillaries; Cyclophosphamide; Doxorubicin; He | 1996 |
Prednisolone reduces experimental arthritis, and inflammatory tissue destruction in SCID mice infected with Borrelia burgdorferi.
Topics: Animals; Arthritis, Infectious; Borrelia burgdorferi Group; Cell Adhesion Molecules; Female; Hemangi | 1996 |
Bilateral adrenal lymphoma with neoplastic angioendotheliosis.
Topics: Acute Kidney Injury; Addison Disease; Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy | 1997 |
Haemangio-endothelioma of the orbit.
Topics: Female; Hemangioendothelioma; Humans; Infant, Newborn; Infant, Newborn, Diseases; Orbital Neoplasms; | 1978 |